Silimarina como potencial agente hepatoprotector

Revista Cadena de Cerebros



Bibliographic data

Translated title: Silymarin as potential hepatoprotective agent
Journal Title: Revista Cadena de Cerebros
Author: María Adelina Jiménez-Arellanes
Palabras clave:
Traslated Keywords:
Language: Spanish
Get full text: https://www.cadenadecerebros.com/art-re-32-02
Resource type: Journal Article
Source: Revista Cadena de Cerebros; Vol 3, No 2 (Year 2019).
Publisher: Fernando Padilla Santamaría
Usage rights: Reconocimiento - NoComercial (by-nc)
Knowledge areas / Categories: Multidisciplinary --> Multidisciplinary Sciences

Statistical data

  • Views
  • Consultations
  • Citation style
  • Share
  • Export record
  • Favourites

Bibliometric data

WOS

Bibliography: Vargas-Mendoza N, Madrigal-Santillán E, MoralesGonzález Á, Esquivel-Soto J, Esquivel-Chirino C, GarcíaLuna y González-Rubio M, et al. Hepatoprotective effect of silymarin. World J Hepatol. 2014; 6(3): 144-9. DOI: 10.4254/wjh.v6.i3.144

Hoekstra LT, de Graaf W, Nibourg GAA, Heger M, Bennink RJ, Stieger B, et al. Physiological and Biochemical Basis of Clinical Liver Function Tests. Annals Surg. 2013; 257(1): 2736. DOI: 10.1097/sla.0b013e31825d5d47

Bertuccio P, Turati F, Carioli G, Rodriguez T, La Vecchia C, Malvezzi M, et al. Global Trends and Predictions in Hepatocellular Carcinoma Mortality. J Hepatol. 2017; 67(2): 302 -9. DOI: 10.1016/j.jhep.2017.03.011

Global Hepatitis Report 2017. 1a Edición. Geneva: World Health Organization; 2017. Disponible en: http://apps.who.int/iris/bitstream/handle/10665/255016/9789241 565455-eng.pdf

Rowe IA. Lessons from Epidemiology: The Burden of Liver Disease. Dig Dis. 2017; 35(4): 304-9. DOI: 10.1159/000456580

Jiménez-Arellanes MA, Gutiérrez-Rebolledo GA, MeckesFischer M, León-Díaz R. Medical plant extracts and natural compounds with a hepatoprotective effect against damage caused by antitubercular drugs: A review. Asian Pac J Trop Med. 2016; 9(12): 1141-9. DOI: 10.1016/ j.apjtm.2016.10.010

Damian D. Efecto hepatoprotector del extracto orgánico de las partes aéreas de Cnidoscolus chayamansa. Tesis de Maestría. Tecnológico de Estudios Superiores de Ecatepec. 2018.

Salwe KJ, Mirunalini R, Mano J, Manimekalai K. Hepatoprotective and antioxidant activity of Murraya Koenigii leaves extract against paracetamol induced hepatotoxicity in Rats. Int J Bas Clin Pharmacol. 2017; 6(6): 1274-81. DOI: 10.18203/2319-2003.ijbcp20172044

Asadi-Samani M, Kafash-Farkhad N, Azimi N, Fasihi A, Alinia-Ahandani E, Rafieian-Kopaei M. Medicinal plants with hepatoprotective activity in Iranian folk medicine. Asian Pac J Trop Biomed. 2015; 5(2): 146-57. DOI: 10.1016/ S2221-1691(15)30159-3

Bailón-Martínez D, Jiménez-Arellanes MA. Efecto hepatoprotector de compuestos naturales, productos biológicos y extractos de plantas medicinales contra el daño provocado por fármacos antituberculosos (Parte II). Rev Mex Cienc Farm. 2018; 49(3): 1-31.

Quezada SM, Briscoe J, Cross RK. Complementary and Alternative Medicine. Inflamm Bowel Dis. 2016; 22(6): 1523-30. DOI: 10.1097/MIB.0000000000000761

Azwanida NN. A Review on the Extraction Methods Use in Medicinal Plants, Principle, Strength and Limitation. Med Arom Plants. 2015; 4(3): 1000196. DOI: 10.4172/21670412.1000196

Comelli MC, Mengs U, Schneider C, Prosdocimi M. Toward the Definition of the Mechanism of Action of Silymarin: Activities Related to Cellular Protection from Toxic Damage Induced by Chemotherapy. Integr Cancer Ther. 2007; 6 (2): 120-9. DOI: 10.1177/1534735407302349

Mastron J, Siveen K, Sethi G, Bishayee A. Silymarin and hepatocellular carcinoma: A systematic, comprehensive and crtical review. Anti-cancer Drugs. 2015; 26(5): 475-86. DOI: 10.1097/cad.0000000000000211

Kumar T, Larokar YK, Iyer SK, Kumar A, Tripathi DK. Phytochemistry and Pharmacological Activities of Silybum marianum: A Review. Int J Pharm Phytopharm Res. 8677; 7(9): 784-33. Disponible en: https://www.academia.edu/2470494/Phytochemistry_and_Pharmacological_Activities_of_Sily bum_marianum_A_Review

Hellerbrand C, Schattenberg JM, Peterburs P, Lechner A, Brignoli R. The potential of silymarin for the treatment of hepatic disorders. Clin Phytosci. 2016; 2(7): 1-14. DOI: 10.1186/s40816-016-0019-2

Kawaguchi-Suzuki M, Frye RF, Zhu HJ, Brinda BJ, Chavin KD, Bernstein HJ, et al. The Effects of Milk Thistle (Silybum marianum) on Human Cytochrome P894 Activity. Drug Metab Dispos. 2014; 42(10): 1611-6. DOI: 10.1124/dmd.114.057232

Ferenci P. Silymarin in the treatment of liver diseases: What is the clinical evidence? Clin Liv Dis (Hoboken). 2016; 7(1): 8-10. DOI: 10.1002/cld.522

Pradhan SC, Girish C. Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine. Indian J Med Res. 2006; 124(5): 491-504. Disponible en: http://www.ijmr.org.in/article.asp?issn=09715916;year=2013;volume=137;issue=2;spage=423;epage=436;aulast=Pradhan;type=0

Hogan FS, Krishnegowda NK, Mikhailova M, Kahlenberg MS. Flavonoid, Silibinin, Inhibits Proliferation and Promotes Cell-Cycle Arrest of Human Colon Cancer. J Surg Res. 2007; 143(1), 58-65. DOI: 10.1016/j.jss.2007.03.080

Jahan S, Khan M, Imran S, Sair M. The hepatoprotective role of Silymarin in isoniazid induced liver damage of rabbits. J Pak Med Assoc. 2015; 65(6): 620-2. Disponible en: https://jpma.org.pk/article-details/7375?article_id=7375

Panchabhai TS, Ambarkhane SV, Joshi AS, Samant BD, Rege NN. Protective Effect of Tinospora cordifolia, Phyllanthus emblica and Their Combination Against Antitubercular Drugs Induced Hepatic Damage: An Experimental Study. Phytother Res. 2008; 22(5): 646-50. DOI: 10.1002/ptr.2356

Clichici S, Olteanu D, Nagy A, Oros A, Filip A, Mircea PA. Silymarin Inhibits the Progression of Fibrosis in the Early Stages of Liver Injury in CCl4-Treated Rats. J Med Food. 2015; 18(3): 290-8. DOI: 10.1089/jmf.2013.0179

Hermenean A, Stan M, Ardelean A, Pilat L, Mihali CV, Popescu C, et al. Antioxidant and hepatoprotective activity of milk thistle (Silybum marianum L. Gaertn.) seed oil. Open Life Sci. 2015; 10(1): 225-36. DOI: 10.1515/biol-2015-0017

Bektur NE, Sahin E, Baycu C, Unver G. Protective effects of silymarin against acetaminophen-induced hepatotoxicity and nephrotoxicity in mice. Toxicol Ind Health. 2013; 32(4): 589-600. DOI: 10.1177/0748233713502841

Pari L, Kumar NA. Hepatoprotective Activity of Moringa oleifera on Antitubercular Drug-Induced Liver Damage in Rats. J Med Food. 2002; 5(3): 171-7. DOI: 10.1089/10966200260398206

Domitrović R, Rashed K, Cvijanović O, Vladimir-Knežević S, Škoda M, Višnić A. Myricitrin exhibits antioxidant, antiinflammatory and antifibrotic activity in carbon tetrachloride-intoxicated mice. Chem Biol Interact. 2015; 230: 21 -9. DOI: 10.1016/j.cbi.2015.01.030

Kim SH, Oh DS, Oh JY, Son TG, Yuk DY, Jung YS. Silymarin Prevents Restraint Stress-Induced Acute Liver Injury by Ameliorating Oxidative Stress and Reducing Inflammatory Response. Molecules. 2016; 21(4): 443. DOI: 10.3390/molecules21040443

Chen IS, Chen YC, Chou CH, Chuang RF, Sheen LY, Chiu CH. Hepatoprotection of silymarin against thioacetamide induced chronic liver fibrosis. J Sci Food Agric. 2012; 92(7): 1441-7. DOI: 10.1002/jsfa.4723

Jaswal A, Sinha N, Bhadauria M, Shrivastava S, Shukla S. Therapeutic potential of thymoquinone against antituberculosis drugs induced liver damage. Environ Toxicol Pharmacol. 2013; 36(3): 779-86. DOI: 10.1016/j.etap.2013.07.010

Rao CV, Rawat A, Singh AP, Singh A, Verma N. Hepatoprotective potential of ethanolic extract of Ziziphus oenoplia (L.) Mill roots against antitubercular drugs induced hepatotoxicity in experimental models. Asian Pac J Trop Med. 2012; 5(4): 283-8. DOI: 10.1016/s1995-7645(12)60040-6

Sozmen M, Devrim AK, Tunca R, Bayezit M, Dag S, Essiz D. Protective effects of silymarin on fumonisin B1-induced hepatotoxicity in mice. J Vet Sci. 2014; 15(1): 51-60. DOI: 10.4142/jvs.2014.15.1.51

Amin KA, Ahmed RR, Hozayen WG, Antar A. Renoprotective and Antioxidant Effects of Silymarin and Propolis on Diclofenac Sodium - Induced Renal Toxicity in Rats. Int J Pure Appl Biosci. 2017; 5(2): 31-42. DOI: 10.18782/23207051.2421

Naik M, Chakraborty M, Ahmed R, Hamza S, Afsal M. Investigation of nefroprotective effect of silymarin against methotrexate and ifosfamide induced toxicity in rats. Int J Pharm Sci Res. 2015; 6(1): 174-9. Disponible en: https://www.semanticscholar.org/paper/INVESTIGATION-OFNEPFROPROTECTIVE-EFFECT-OF-AGAINST-Naik-Chakraborty/00d48d4f16d7cf6997b40c6f7ef4a667fc84b0af

Gopi K, Reddy A, Jyothi K, Kumar B. Acetaminopheninduced Hepato- and Nephrotoxicity and Amelioration by Silymarin and Terminalia chebula in Rats. Toxicol Int. 2010; 17(2): 64-6. DOI: 10.4103/0971-6580.72672

Shahbazi F, Dashti-Khavidaki S, Khalili H, Lessan-Pezeshki M. Potential renoprotective effects of silymarin against nephrotoxic drugs: A review of literature. J Pharm Pharmaceut Sci. 2012; 15(1): 112-23. DOI: 10.18433/J3F88S

Gaedeke J, Fels LM, Bokemeyer C, Mengs U, Stolte H, Lentzen H. Cisplatin nephrotoxicity and protection by silibinin. Nephrol Dial Transplant. 1996; 11(1): 55-62.

Bailón D. Evaluación del efecto hepatoprotector de Rosmarinus officinalis y la mezcla de triterpenos contra el daño inducido por fármacos antituberculosos. Tesis Maestría. Instituto Politécnico Nacional. 2016.

Rasool M, Iqbal J, Malik A, Ramzan HS, Qureshi MS, Asif M, et al. Hepatoprotective Effects of Silybum marianum (Silymarin) and Glycyrrhiza glabra (Glycyrrhizin) in Combination: A Possible Synergy. Evid Based Complement Alternat Med. 2014; 2014: 641597. DOI: 10.1155/2014/641597

Kim SH, Cheon HJ, Yun N, Oh ST, Shin E, Shim KS, et al. Protective Effect of a Mixture of Aloe vera and Silybum marianum Against Carbon Tetrachloride–Induced Acute Hepatotoxicity and Liver Fibrosis. J Pharmacol Sci. 2009; 109(1): 119-27. DOI: 10.1254/jphs.08189fp

Jashitha M, Chakraborty M, Kamath JV. Effect of quercetin on hepatoprotective activity of silymarin against thioacetamide intoxicated rats. Int Res J Pharm. 2013; 4(7): 138-40. DOI: 10.7897/2230-8407.04730

Giacomelli S, Gallo D, Apollonio P, Ferlini C, Distefano M, Morazzoni P, et al. Silybin and its bioavailable phospholipid complex (IdB 1016) potentiate in vitro and in vivo the activity of cisplatin. Life Sci. 2002; 70(12): 1447-59. DOI: 10.1016/s0024-3205(01)01511-9

Javed S, Ahsan W, Kohli K. Pharmacological influences of natural products as bioenhancers of silymarin against carbon tetrachloride-induced hepatotoxicity in rats. Clin Phytosci 2018; 4(1): 18. DOI: 10.1186/s40816-018-0079-6

Nada SA, Gowife AMH, El-Denshary EES, Salama AA, Khali MG, Ahmed KA. Protective Effect of Grape Seed Extract and/or Silymarin Against Thioacetamide-induced Hepatic Fibrosis in Rats. J Liver. 2015; 4(2): 1-7. DOI: 10.4172/21670889.1000178

Ghosh A, Ghosh T, Jain S. Silymarin-A review on the pharmacodynamics and bioavailability enhancement approaches. J Pharm Sci Techn. 2010; 2(10): 348-55. Disponible en: http://www.onlinepharmacytech.info/docs/vol2issue10/JPST10-02-10-04.pdf

Luangchosiri C, Thakkinstian A, Chitphuk S, Stitchantrakul W, Petraksa S, Sobhonslidsuk A. A double-blinded randomized controlled trial of silymarin for the prevention of antituberculosis drug-induced liver injury. BMC Complement Altern Med. 2015; 15(334): 1-7. DOI: 10.1186/s12906015-0861-7

Luangchosiri C, Thakkinstian A, Chitphuk S, Stitchantrakul W, Petraksa S, Sobhonslidsuk A. A double-blinded randomized controlled trial of silymarin for the prevention of antituberculosis drug-induced liver injury. BMC Complement Altern Med. 2015; 15(334): 1-7. DOI: 10.1186/s12906015-0861-7

Huseini HF, Larijani B, Heshmat R, Fakhrzadeh H, Radjabipour B, Toliat T, et al. The efficacy of Silybum marianum (L.) Gaertn. (silymarin) in the treatment of type II diabetes: a randomized, double-blind, placebo-controlled, clinical trial. Phytother Res. 2006; 20(12): 1036-9. DOI: 10.1002/ptr.1988

Hagag A, Elgamsy M, El-Asy H, Mabrouk M. Protective Role of Silymarin on Hepatic and Renal Toxicity Induced by MTX Based Chemotherapy in Children with Acute Lymphoblastic Leukemia. Mediterr J Hematol Infect Dis. 2016; 8(1): 1-9. DOI: 10.4084/MJHID.2016.043

Roozbeh J, Shahriyari B, Akmali M, Vessal G, Pakfetrat M, Jalali GAR, et al. Comparative Effects of Silymarin and Vitamin E Supplementation on Oxidative Stress Markers, and Hemoglobin Levels Among Patients on Hemodialysis. Ren Fail. 2011; 33(2): 118-23. DOI: 10.3109/0886022x.2010.541579

Salmond S, George J, Strasser S, Byth K, Rawlinson B, Mori T, et al. Hep573 Study: A randomised, double-blind, placebo-controlled trial of silymarin alone and combined with antioxidants to improve liver function and quality of life in people with chronic hepatitis C. Aust J Herb Med. 2018; 30 (1): 12-25.

Fried MW, Navarro VJ, Afdhal N, Belle SH, Wahed AS, Hawke RL, et al. Effect of Silymarin (Milk Thistle) on Liver Disease in Patients with Chronic Hepatitis C Unsuccessfully Treated with Interferon Therapy A Randomized Controlled Trial. JAMA. 2012; 308(3): 274-82. DOI: 10.1001/jama.2012.8265

Tanamly M, Tadros F, Labeeb S, Makld H, Shehata M, Mikhail N, et al. Randomised double-blinded trial evaluating silymarin for chronic hepatitis C in an Egyptian village: study description and 12-month results. Dig Liver Dis. 2004; 36(11): 752-9. DOI: 10.1016/j.dld.2004.06.015